Microbiota Modulation in Bariatric Surgery Outcomes

Bariatric surgery, including Roux-en-Y gastric bypass and sleeve gastrectomy, is established as the most effective treatment for severe obesity. Beyond mechanical restriction and hormonal changes, these procedures elicit profound and sustained reconfiguration of the gut microbiota. Patients typically exhibit an early drop in microbial diversity followed by a gradual restoration, alongside persistent shifts in key bacterial groups. These compositional changes influence host metabolism through altered fermentation profiles, modified bile acid pools and regulation of gut hormones such as glucagon-like peptide-1 and peptide YY. The resulting microbial–host crosstalk contributes to improved insulin sensitivity, reduced systemic inflammation and enhanced appetite control. Understanding these dynamics offers opportunities to refine postoperative care through personalised dietary strategies, prebiotic and probiotic interventions, and microbial biomarkers for optimising long-term outcomes.

Research from Nature Portfolio

Recent studies have demonstrated that both sleeve gastrectomy and Roux-en-Y gastric bypass induce immediate declines in microbial diversity followed by a return to baseline over six months, alongside permanent compositional shifts. These include increases in Proteobacteria and decreases in Firmicutes such as Faecalibacterium. Metagenomic analyses reveal enhanced microbial capacity for nutrient transport, aerobic respiration and amino-acid metabolism. Importantly, microbial alterations appear largely independent of surgical technique, highlighting a common microbiological signature of bariatric surgery that may drive weight-loss maintenance and metabolic benefit.

Microbiota Modulation in Bariatric Surgery Outcomes publication trend

The graph below shows the total number of articles in microbiota modulation in bariatric surgery outcomes across all publications each year (not limited to Nature Index journals).

Technical terms

Alpha-diversity: A measure of microbial species richness and evenness within a single sample.

Beta-diversity: A comparison of microbial community composition between different samples.

Short-chain fatty acids (SCFAs): Metabolic products of bacterial fermentation of dietary fibres, influencing host energy metabolism and gut hormone secretion.

Roux-en-Y gastric bypass (RYGB): A bariatric procedure that creates a small gastric pouch and reroutes the small intestine to promote weight loss.

Sleeve gastrectomy (SG): A surgical weight-loss method involving removal of a large portion of the stomach to restrict intake and alter gut physiology.

References

1. Short-Chain Fatty Acids—A Product of the Microbiome and Its Participation in Two-Way Communication on the Microbiome-Host Mammal Line. Current Obesity Reports (2023).
2. Effects of gastric bypass bariatric surgery on gut microbiota in patients with morbid obesity. Gut Microbes (2024).
3. Associations between the gut microbiome and metabolic, inflammatory, and appetitive effects of sleeve gastrectomy. Obesity Reviews (2023).
4. Effect of inulin on breath hydrogen, postprandial glycemia, gut hormone release, and appetite perception in RYGB patients: a prospective, randomized, cross-over pilot study. Nutrition & Diabetes (2024).
5. Roux-en-Y gastric bypass surgery of morbidly obese patients induces swift and persistent changes of the individual gut microbiota. Genome Medicine (2016).
6. Roux-Y Gastric Bypass and Sleeve Gastrectomy directly change gut microbiota composition independent of surgery type. Scientific Reports (2019).
7. Temporospatial shifts in the human gut microbiome and metabolome after gastric bypass surgery. npj Biofilms and Microbiomes (2020).